The Trump administration has reached an agreement with researchers and Democratic-led states who filed a lawsuit over cuts to diversity-related research funding at the National Institutes of Health (NIH). The deal, announced Monday, allows stalled or rejected grant applications to move forward for review after months of legal uncertainty surrounding diversity, equity, and inclusion (DEI) research funding.
The dispute began after the NIH canceled hundreds of millions of dollars in research grants, citing concerns that the projects were tied to DEI initiatives rather than core scientific objectives. In response, affected researchers and states sued the federal government, arguing that the funding cuts were unlawful and arbitrary. Earlier this year, U.S. District Judge William Young ruled in Boston that the NIH had improperly terminated the grants, finding that the cancellations violated federal law.
However, the legal battle became more complex in August when the U.S. Supreme Court partially paused Judge Young’s ruling. The high court determined that claims related to the terminated grants should be heard by a specialized federal court that handles monetary disputes with the government. At the same time, the Supreme Court left unresolved a separate issue regarding how the NIH handled applications for future research funding.
Monday’s agreement addresses that unresolved portion of the case. Under the deal, the federal government has agreed to conduct new reviews of grant applications that were frozen, denied, or withdrawn after the policy change was announced. Importantly, the agreement does not require the NIH to approve or fund any specific research proposals, but it does reopen the door for fair consideration.
The researchers involved say the affected grants cover critical public health areas, including HIV prevention, Alzheimer’s disease, LGBTQ health, and sexual violence research. One of the plaintiffs, Nikki Maphis, a postdoctoral researcher at the University of New Mexico, welcomed the development, saying it allows her Alzheimer’s and aging brain research to move forward after what she described as an “arbitrary and destructive freeze.”
The agreement does not affect Judge Young’s earlier ruling blocking the NIH policy itself. The U.S. Department of Health and Human Services has appealed that decision and maintains that it ended funding for research it believes prioritized ideology over scientific rigor.


Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Supreme Court Signals Skepticism Toward Hawaii Handgun Carry Law
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
Supreme Court Signals Doubts Over Trump’s Bid to Fire Fed Governor Lisa Cook
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Trump Allows Commercial Fishing in Protected New England Waters
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Netanyahu to Meet Trump in Washington as Iran Nuclear Talks Intensify
Jack Lang Resigns as Head of Arab World Institute Amid Epstein Controversy
California Sues Trump Administration Over Federal Authority on Sable Offshore Pipelines
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links 



